Cargando…
Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
Background The Coronavirus disease-2019 (COVID-19) is a global pandemic. Acute respiratory compromise and systemic coagulopathy cause significant morbidity and mortality. Venous thromboembolism (VTE), which encompasses both deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as arterial...
Autores principales: | Warrior, Surbhi, Behrens, Elizabeth, Thomas, Joshua, Rajakumar, Priya, Gezer, Sefer, Venugopal, Parameswaran, Jain, Shivi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330240/ http://dx.doi.org/10.1182/blood-2020-137707 |
Ejemplares similares
-
Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020) -
Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?
por: Marquez, Félix Gibrant, et al.
Publicado: (2020) -
COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic
por: Almukhtar, Talat, et al.
Publicado: (2020) -
Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021) -
The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
por: Zheng, Rena, et al.
Publicado: (2021)